about
Analysis and characterization of heparin impuritiesFucoidans in NanomedicineChemoenzymatic synthesis of heparan sulfate and heparinEngineering of routes to heparin and related polysaccharidesGlycotherapy: new advances inspire a reemergence of glycans in medicineUnderstanding the substrate specificity of the heparan sulfate sulfotransferases by an integrated biosynthetic and crystallographic approachDissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparinStable isotopic analysis of porcine, bovine, and ovine heparinsStructural and haemostatic features of pharmaceutical heparins from different animal sources: challenges to define thresholds separating distinct drugsNew methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues.In vitro and in vivo characterization of a reversible synthetic heparin analog.Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities.Chemoenzymatic design of heparan sulfate oligosaccharidesMolecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase.Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharidesOzonolysis of the double bond of the unsaturated uronate residue in low-molecular-weight heparin and K5 heparosan.Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.Is N-acetyl-D-glucosamine a rigid 4C1 chair?Characterization of currently marketed heparin products: analysis of molecular weight and heparinase-I digest patterns.Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparinsDependence of pyranose ring puckering on anomeric configuration: methyl idopyranosidesE. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor.Heparin mapping using heparin lyases and the generation of a novel low molecular weight heparinHexosamine analogs: from metabolic glycoengineering to drug discovery.Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogsChemoenzymatic synthesis of glycosaminoglycans: re-creating, re-modeling and re-designing nature's longest or most complex carbohydrate chains.Synthesis and anticoagulant activity of polyureas containing sulfated carbohydratesExpression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3'-phosphoadenosine-5'-phosphosulfate.FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.Escherichia coli K5 heparosan fermentation and improvement by genetic engineering.Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.Improvement of the digestibility of sulfated hyaluronans by bovine testicular hyaluronidase: a UV spectroscopic and mass spectrometric studyCombinatorial one-pot chemoenzymatic synthesis of heparin.Mass balance analysis of contaminated heparin product.High cell density cultivation of recombinant Escherichia coli strains expressing 2-O-sulfotransferase and C5-epimerase for the production of bioengineered heparin.Exopolysaccharides produced by marine bacteria and their applications as glycosaminoglycan-like moleculesHomogeneous low-molecular-weight heparins with reversible anticoagulant activity.Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin
P2860
Q24605666-2E6B2B86-A210-4929-989B-B249D3196C75Q26739976-8C797DD7-12B7-4A16-B24A-FEECC56FEE13Q27005958-FD6F392B-CE91-4BED-9BA2-B3BAE50DCCDDQ27013519-C7A0672F-F7D2-4DA5-A962-BFD09D36D868Q27027997-9BEEB422-C7BE-445D-A88F-42B1ADA4E456Q27028136-B44C0767-6FC0-4EBD-96E4-4BEE0173977FQ27678106-3F723D6D-1210-44E8-9D4D-CD083EFADA7CQ28650853-052FCD1F-7AF5-4E81-9A1A-293385FC019CQ28821880-A409AA71-1B3C-4CEE-9B19-A83C45B4C4DDQ30603210-0F80D2BE-2FAE-4CC7-8E5E-7CC2FBB8E7BFQ30710756-2D62F7B6-475D-4EF4-8262-A70EDC8FDBCAQ33402197-B4A65E7D-87F0-4763-9445-2678F764CB20Q33668533-5E9DF5E5-061A-4865-A235-DD841FE863ADQ33676686-419ED6E7-4EB5-438C-A640-88A69D29EBF7Q33748076-5BB8795E-81A8-46DB-B155-AF05BC2902ECQ33806757-1D091434-805F-4800-BFF4-231D7E555582Q33956418-DB8447DC-6CE7-4E6E-8BFE-0E5E1A788286Q33957321-103BFC35-BFD7-467A-875C-AEFB6043538EQ33978044-D3D5142B-891F-4110-B764-513AEFD211F4Q34013926-DD963AAD-80BA-4C24-B98F-27828827179FQ34228210-5D411B93-4B31-4AEF-BB25-FDD30FAEE986Q34266245-76C8E5E5-B5DB-4357-AC31-FDC444C989A1Q34283201-1E062D81-5FEA-459B-850C-9783FAB29B1AQ34507805-A1816367-2DDC-4FA8-BDF6-1F3F6B6D6F6AQ34573479-1EB5C59E-0E5F-4F37-ADAF-1BD00A8507ECQ34573505-1BFA408B-4530-4E32-9A32-4783722FD47AQ34616858-B84BCA9E-3EA1-468B-BF6F-65ABBECA9E12Q34669693-9238EC88-479D-4431-889F-551FB79AF9CFQ34966755-431FF2F8-CD8D-4937-9136-3B45C6366467Q35056506-F219F14A-19AD-4246-A553-3CC6497711CCQ35078981-A924E27D-313D-4EC0-84A1-85132E525082Q35157452-D6EB1CD4-8DC1-4A35-8F89-9BD4FBFB87C6Q35196193-1CC55FEC-3283-4F49-9332-608059F6DCABQ35232430-55556CFB-3332-4C81-B671-42B62AA8E4A1Q35234372-D544C73D-DDA6-463D-B2AF-F5A2744E7066Q35285327-8BA59623-002D-4DC4-B8AF-BBE4F80A8F46Q35360491-26011DF5-5823-49A0-9338-1429BFE10CACQ35361517-25B9C242-7910-4964-B2D0-26679D612F8DQ35987516-69FA11FD-2896-4C77-A8EF-5C2C414AF842Q36015630-2656BAC5-9DAD-4E7F-A835-CDA1A8F22907
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Lessons learned from the contamination of heparin.
@ast
Lessons learned from the contamination of heparin.
@en
type
label
Lessons learned from the contamination of heparin.
@ast
Lessons learned from the contamination of heparin.
@en
prefLabel
Lessons learned from the contamination of heparin.
@ast
Lessons learned from the contamination of heparin.
@en
P2860
P356
P1476
Lessons learned from the contamination of heparin.
@en
P2093
Haiying Liu
Zhenqing Zhang
P2860
P304
P356
10.1039/B819896A
P577
2009-01-19T00:00:00Z